Implication of renal prostaglandin E in urinary sodium excretion. 1978

M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga

To investigate the role of renal prostaglandin in the regulation of sodium metabolism, ruinary prostaglandin E excretion, an indicator of renal prostaglandin synthesis, urinary sodium excretion, plasma renin activity and urinary aldosterone excretion were measured in 84 normal subjects and 55 patients with essential hypertension on ad lib intake of sodium. The excretion rates of urinary prostaglandin E were 736.8 +/- 32.2 ng/day in normal subjects and 394.3 +/- 28.7 ng/day in essential hypertensives. The excretion rate was significantly decreased in essential hypertensives (P less than 0.001). A significant positive correlation was found between urinary sodium excretion and urinary prostaglandin E excretion in normal subjects (r = 0.39, P less than 0.001), and in essential hypertensives (r = 0.62, P less than 0.001). There was no correlation between the renin-angiotensin-aldosterone system and urinary prostaglandin E excretion in normal subjects as well as in essential hypertensives. The present data show that renal prostaglandin might be involved in the renal handling of sodium, and prove the possibility that the decrease of renal prostaglandin synthesis is one of the etiological factors in essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
October 1976, Experientia,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
October 1978, Prostaglandins,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
May 1980, Prostaglandins and medicine,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
January 1987, Contributions to nephrology,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
May 1978, Acta physiologica Scandinavica,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
April 1981, Japanese journal of pharmacology,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
January 1980, Biology of the neonate,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
October 1987, Prostaglandins,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
April 1983, Nihon Jinzo Gakkai shi,
M Yasujima, and K Abe, and S Chiba, and M Sato, and N Irokawa, and M Seino, and Y Imai, and K Saito, and Y Sakurai, and T Ito, and T Haruyama, and K Ritsu, and K Yoshinaga
January 1980, Prostaglandins and medicine,
Copied contents to your clipboard!